Scotts Miracle-Gro stock: UBS cuts target for Scotts Miracle-Gro stock to USD 70.00

Published on 10/24/2026 at 05:38 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

UBS moved the rating to Buy from Neutral on October 15, 2026. The USD 70.00 target for Scotts Miracle-Gro stock follows USD 78.00, with fiscal 2026 adjusted EPS guidance at USD 4.30-4.45.

Guidance and analyst revision

UBS moved Scotts Miracle-Gro to Buy from Neutral on October 15, 2026.
Fiscal third-quarter revenue reached USD 1.17 billion in 2026.
Market capitalization stood at USD 3.5 billion as of October 23, 2026.

SMG, US8101861065, Illustration mit AI erstellt.

The Scotts Miracle-Gro Company (US8101861065) became the subject of a UBS rating change after the bank moved the stock to Buy from Neutral and cut its target from USD 78.00 to USD 70.00 on October 15, 2026, according to Investing.com. The decision keeps valuation and execution at the center of the debate.

Three developments shape the story

The company delivered fiscal third-quarter 2026 adjusted earnings per share of USD 2.82 against a USD 2.48 estimate, while revenue increased 1.00 percent to USD 1.17 billion. Yahoo Finance also reported that Scotts raised fiscal 2026 adjusted earnings-per-share guidance to USD 4.30-4.45 from USD 4.15-4.35.

Chronology matters. On July 29, 2026, fiscal third-quarter adjusted earnings per share reached USD 2.82; on October 6, 2026, the company announced a chief information officer appointment tied to its SMG 2.0 strategy; on October 15, 2026, UBS changed its rating to Buy and set a USD 70.00 target. The October 6 announcement appears on the company investor-relations page at The Scotts Miracle-Gro Company.

What does the margin data show?

Fiscal 2026 year-to-date GAAP gross margin was 35.70 percent, up 130 basis points from the prior year. The non-GAAP rate was 35.80 percent versus 34.70 percent a year earlier, while year-to-date adjusted EBITDA rose 5.00 percent to USD 686.6 million, according to the earnings-call transcript.

Dates investors can track

The next explicitly listed reporting date is November 4, 2026, when the company plans to hold its fiscal fourth-quarter 2026 earnings conference call. The investor-relations calendar labels the event tentative.

Valuation sets the market frame

The stock closed at USD 59.29 on the NYSE on October 23, 2026, at 4:00 p.m. EDT, while market capitalization stood at USD 3.5 billion. The same quote showed a 52-week range of USD 47.90 to USD 75.34. The UBS target therefore remains a valuation reference, while the guidance range supplies the key operating test.

The further course of trading is shown by the continuously updated real-time quote of Scotts Miracle-Gro stock.